Effect of finerenone across the stages of heart failure: From prevention to treatment.
Publication
, Journal Article
Biegus, J; Palazzuoli, A; Greene, SJ
Published in: Eur J Heart Fail
May 2025
Duke Scholars
Published In
Eur J Heart Fail
DOI
EISSN
1879-0844
Publication Date
May 2025
Volume
27
Issue
5
Start / End Page
775 / 778
Location
England
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Biegus, J., Palazzuoli, A., & Greene, S. J. (2025). Effect of finerenone across the stages of heart failure: From prevention to treatment. Eur J Heart Fail, 27(5), 775–778. https://doi.org/10.1002/ejhf.3606
Biegus, Jan, Alberto Palazzuoli, and Stephen J. Greene. “Effect of finerenone across the stages of heart failure: From prevention to treatment.” Eur J Heart Fail 27, no. 5 (May 2025): 775–78. https://doi.org/10.1002/ejhf.3606.
Biegus J, Palazzuoli A, Greene SJ. Effect of finerenone across the stages of heart failure: From prevention to treatment. Eur J Heart Fail. 2025 May;27(5):775–8.
Biegus, Jan, et al. “Effect of finerenone across the stages of heart failure: From prevention to treatment.” Eur J Heart Fail, vol. 27, no. 5, May 2025, pp. 775–78. Pubmed, doi:10.1002/ejhf.3606.
Biegus J, Palazzuoli A, Greene SJ. Effect of finerenone across the stages of heart failure: From prevention to treatment. Eur J Heart Fail. 2025 May;27(5):775–778.
Published In
Eur J Heart Fail
DOI
EISSN
1879-0844
Publication Date
May 2025
Volume
27
Issue
5
Start / End Page
775 / 778
Location
England
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology